ドセタキセル、パクリタキセル、ベバシズマブ、リツキシマブなどの抗腫瘍注射剤は、乳がん、肺がん、前立腺がんなどのがんを標的とした強力ながん治療薬を静脈注射で投与します。この分野は、がん発生率の上昇と生物学的製剤の革新により、精度、迅速な効果、病院での投与で成長しています。市場は、高コスト、バイオシミラーとの競争、複雑な製造要件に直面しています。
世界の抗腫瘍注射市場は、2025年には500億〜600億米ドルと評価され、2025年から2030年にかけて6.5%〜8.0%のCAGRで成長し、2030年までに700億〜850億米ドルにすると予想されています。
北アメリカは35〜40%を占め、5.5〜6.5%で成長しています。アメリカは先進的な腫瘍治療と生物学的製剤でリードしており、バイオシミラーへの傾向が見られます。カナダは安定した需要でそれに続いています。ヨーロッパは25〜30%を占め、5.0〜6.0%で成長しています。ドイツとイギリスは、ジェネリックを重視し、病院に焦点を当てて使用を促進しています。アジア太平洋地域は25〜30%を占め、8.5〜10.0%で成長しています。中国とインドは、手頃な価格で現地生産を拡大しています。その他の地域は10〜15%で、6.0〜7.0%で成長しており、ブラジルはアクセスを優先しています。
乳がんは20〜25%を占め、6.0〜7.0%で成長しており、タキサンが牽引し、併用療法の傾向にあります。胃がんは10〜15%を占め、5.5〜6.5%で成長しており、ドセタキセルに焦点が当てられています。卵巣がんは10〜15%を占め、6.5〜7.5%で成長しており、パクリタキセルの傾向にあります。肺がんは15〜20%を占め、7.0〜8.0%で成長しており、生物学的製剤が牽引しています。精巣がんは5〜10%を占め、5.5〜6.5%で成長しており、ニッチな使用が進んでいます。子宮頸がんは5〜10%を占め、6.0〜7.0%で成長しており、新しい治療法が進んでいます。子宮内膜がんは5〜10%を占め、6.0〜7.0%で成長しており、標的を絞った治療に焦点が当てられています。前立腺がんは5〜10%を占め、生物学的傾向により6.5〜7.5%の割合で増加しています。膀胱がんは5〜10%を占め、病院での使用により6.0〜7.0%の割合で増加しています。その他のがんは、増加率が一定ではありません。
ドセタキセル注射は25〜30%を占め、6.0〜7.0%で成長しており、幅広い有効性が評価され、ジェネリック医薬品のトレンドが見られます。パクリタキセル注射は25〜30%を占め、5.5〜6.5%で成長しており、併用療法に注力しています。ベバシズマブ注射は15〜20%を占め、7.5〜8.5%で成長しており、バイオシミラーのトレンドが見られます。アダリムマブ注射は10〜15%を占め、6.5〜7.5%で成長しており、ニッチな腫瘍学で使用されています。リツキシマブ注射は10〜15%を占め、7.0〜8.0%で成長しており、免疫療法のトレンドが見られます。その他は、新興生物製剤の登場により、6.0〜7.0%で成長しています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Tumor Injection Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Tumor Injection Market in North America (2020-2030)
8.1 Anti-Tumor Injection Market Size
8.2 Anti-Tumor Injection Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Tumor Injection Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Tumor Injection Market in South America (2020-2030)
9.1 Anti-Tumor Injection Market Size
9.2 Anti-Tumor Injection Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Tumor Injection Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Tumor Injection Market in Asia & Pacific (2020-2030)
10.1 Anti-Tumor Injection Market Size
10.2 Anti-Tumor Injection Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Tumor Injection Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Tumor Injection Market in Europe (2020-2030)
11.1 Anti-Tumor Injection Market Size
11.2 Anti-Tumor Injection Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Tumor Injection Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Tumor Injection Market in MEA (2020-2030)
12.1 Anti-Tumor Injection Market Size
12.2 Anti-Tumor Injection Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Tumor Injection Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Tumor Injection Market (2020-2025)
13.1 Anti-Tumor Injection Market Size
13.2 Anti-Tumor Injection Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Tumor Injection Market Size by Type
Chapter 14 Global Anti-Tumor Injection Market Forecast (2025-2030)
14.1 Anti-Tumor Injection Market Size Forecast
14.2 Anti-Tumor Injection Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Tumor Injection Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Anti-tumor Injection Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.2 Bayer
15.2.1 Company Profile
15.2.2 Main Business and Anti-tumor Injection Information
15.2.3 SWOT Analysis of Bayer
15.2.4 Bayer Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Anti-tumor Injection Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.4 Pfizer
15.4.1 Company Profile
15.4.2 Main Business and Anti-tumor Injection Information
15.4.3 SWOT Analysis of Pfizer
15.4.4 Pfizer Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.5 Amgen
15.5.1 Company Profile
15.5.2 Main Business and Anti-tumor Injection Information
15.5.3 SWOT Analysis of Amgen
15.5.4 Amgen Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.6 Mabxience
15.6.1 Company Profile
15.6.2 Main Business and Anti-tumor Injection Information
15.6.3 SWOT Analysis of Mabxience
15.6.4 Mabxience Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.7 Luoxin Pharmaceutical
15.7.1 Company Profile
15.7.2 Main Business and Anti-tumor Injection Information
15.7.3 SWOT Analysis of Luoxin Pharmaceutical
15.7.4 Luoxin Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.8 Qilu Pharmaceutical
15.8.1 Company Profile
15.8.2 Main Business and Anti-tumor Injection Information
15.8.3 SWOT Analysis of Qilu Pharmaceutical
15.8.4 Qilu Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.9 Zhejiang Borui Biopharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Anti-tumor Injection Information
15.9.3 SWOT Analysis of Zhejiang Borui Biopharmaceutical
15.9.4 Zhejiang Borui Biopharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.10 Fuxing Medicine
15.10.1 Company Profile
15.10.2 Main Business and Anti-tumor Injection Information
15.10.3 SWOT Analysis of Fuxing Medicine
15.10.4 Fuxing Medicine Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
15.11 Yuekang Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Anti-tumor Injection Information
15.11.3 SWOT Analysis of Yuekang Pharmaceutical
15.11.4 Yuekang Pharmaceutical Anti-tumor Injection Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Tumor Injection Report
Table Data Sources of Anti-Tumor Injection Report
Table Major Assumptions of Anti-Tumor Injection Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Tumor Injection Picture
Table Anti-Tumor Injection Classification
Table Anti-Tumor Injection Applications
Table Drivers of Anti-Tumor Injection Market
Table Restraints of Anti-Tumor Injection Market
Table Opportunities of Anti-Tumor Injection Market
Table Threats of Anti-Tumor Injection Market
Table Covid-19 Impact For Anti-Tumor Injection Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Tumor Injection
Table Cost Structure Analysis of Anti-Tumor Injection
Table Key End Users
Table Latest News of Anti-Tumor Injection Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Tumor Injection Market
Table Policy of Anti-Tumor Injection Market
Table 2020-2030 North America Anti-Tumor Injection Market Size
Figure 2020-2030 North America Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 North America Anti-Tumor Injection Market Size by Application
Table 2020-2025 North America Anti-Tumor Injection Key Players Revenue
Table 2020-2025 North America Anti-Tumor Injection Key Players Market Share
Table 2020-2030 North America Anti-Tumor Injection Market Size by Type
Table 2020-2030 United States Anti-Tumor Injection Market Size
Table 2020-2030 Canada Anti-Tumor Injection Market Size
Table 2020-2030 Mexico Anti-Tumor Injection Market Size
Table 2020-2030 South America Anti-Tumor Injection Market Size
Figure 2020-2030 South America Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 South America Anti-Tumor Injection Market Size by Application
Table 2020-2025 South America Anti-Tumor Injection Key Players Revenue
Table 2020-2025 South America Anti-Tumor Injection Key Players Market Share
Table 2020-2030 South America Anti-Tumor Injection Market Size by Type
Table 2020-2030 Brazil Anti-Tumor Injection Market Size
Table 2020-2030 Argentina Anti-Tumor Injection Market Size
Table 2020-2030 Chile Anti-Tumor Injection Market Size
Table 2020-2030 Peru Anti-Tumor Injection Market Size
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size
Figure 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size by Application
Table 2020-2025 Asia & Pacific Anti-Tumor Injection Key Players Revenue
Table 2020-2025 Asia & Pacific Anti-Tumor Injection Key Players Market Share
Table 2020-2030 Asia & Pacific Anti-Tumor Injection Market Size by Type
Table 2020-2030 China Anti-Tumor Injection Market Size
Table 2020-2030 India Anti-Tumor Injection Market Size
Table 2020-2030 Japan Anti-Tumor Injection Market Size
Table 2020-2030 South Korea Anti-Tumor Injection Market Size
Table 2020-2030 Southeast Asia Anti-Tumor Injection Market Size
Table 2020-2030 Australia Anti-Tumor Injection Market Size
Table 2020-2030 Europe Anti-Tumor Injection Market Size
Figure 2020-2030 Europe Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 Europe Anti-Tumor Injection Market Size by Application
Table 2020-2025 Europe Anti-Tumor Injection Key Players Revenue
Table 2020-2025 Europe Anti-Tumor Injection Key Players Market Share
Table 2020-2030 Europe Anti-Tumor Injection Market Size by Type
Table 2020-2030 Germany Anti-Tumor Injection Market Size
Table 2020-2030 France Anti-Tumor Injection Market Size
Table 2020-2030 United Kingdom Anti-Tumor Injection Market Size
Table 2020-2030 Italy Anti-Tumor Injection Market Size
Table 2020-2030 Spain Anti-Tumor Injection Market Size
Table 2020-2030 Belgium Anti-Tumor Injection Market Size
Table 2020-2030 Netherlands Anti-Tumor Injection Market Size
Table 2020-2030 Austria Anti-Tumor Injection Market Size
Table 2020-2030 Poland Anti-Tumor Injection Market Size
Table 2020-2030 Russia Anti-Tumor Injection Market Size
Table 2020-2030 MEA Anti-Tumor Injection Market Size
Figure 2020-2030 MEA Anti-Tumor Injection Market Size and CAGR
Table 2020-2030 MEA Anti-Tumor Injection Market Size by Application
Table 2020-2025 MEA Anti-Tumor Injection Key Players Revenue
Table 2020-2025 MEA Anti-Tumor Injection Key Players Market Share
Table 2020-2030 MEA Anti-Tumor Injection Market Size by Type
Table 2020-2030 Egypt Anti-Tumor Injection Market Size
Table 2020-2030 Israel Anti-Tumor Injection Market Size
Table 2020-2030 South Africa Anti-Tumor Injection Market Size
Table 2020-2030 Gulf Cooperation Council Countries Anti-Tumor Injection Market Size
Table 2020-2030 Turkey Anti-Tumor Injection Market Size
Table 2020-2025 Global Anti-Tumor Injection Market Size by Region
Table 2020-2025 Global Anti-Tumor Injection Market Size Share by Region
Table 2020-2025 Global Anti-Tumor Injection Market Size by Application
Table 2020-2025 Global Anti-Tumor Injection Market Share by Application
Table 2020-2025 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2020-2025 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2020-2025 Global Anti-Tumor Injection Key Vendors Market Share
Table 2020-2025 Global Anti-Tumor Injection Market Size by Type
Table 2020-2025 Global Anti-Tumor Injection Market Share by Type
Table 2025-2030 Global Anti-Tumor Injection Market Size by Region
Table 2025-2030 Global Anti-Tumor Injection Market Size Share by Region
Table 2025-2030 Global Anti-Tumor Injection Market Size by Application
Table 2025-2030 Global Anti-Tumor Injection Market Share by Application
Table 2025-2030 Global Anti-Tumor Injection Key Vendors Revenue
Figure 2025-2030 Global Anti-Tumor Injection Market Size and Growth Rate
Table 2025-2030 Global Anti-Tumor Injection Key Vendors Market Share
Table 2025-2030 Global Anti-Tumor Injection Market Size by Type
Table 2025-2030 Anti-Tumor Injection Global Market Share by Type
